|
|
Volumn 32, Issue 2, 2000, Pages 413-417
|
|
A randomized, placebo-controlled study to evaluate the efficacy of 12- month famciclovir treatment in patients with chronic hepatitis B e antigen- positive hepatitis B
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
FAMCICLOVIR;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
PLACEBO;
VIRUS DNA;
ADOLESCENT;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
HUMAN TISSUE;
LIVER HISTOLOGY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
VIRUS INHIBITION;
|
|
EID: 0033867220
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2000.9407 Document Type: Article |
|
Times cited : (76)
|
|
References (15)
|
